Liver cancer: Regorafenib as second-line therapy in hepatocellular carcinoma
Liver cancer: Regorafenib as second-line therapy in hepatocellular carcinoma
About this item
Full title
Liver cancer: Regorafenib as second-line therapy in hepatocellular carcinoma
Author / Creator
Publisher
England: Nature Publishing Group
Journal title
Nature reviews. Gastroenterology & hepatology, 2017-03, Vol.14 (3), p.141-142
Language
English
Formats
Publication information
Publisher
England: Nature Publishing Group
Subjects
More information
Alternative Titles
Full title
Liver cancer: Regorafenib as second-line therapy in hepatocellular carcinoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1866296700
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1866296700
Other Identifiers
ISSN
1759-5045
E-ISSN
1759-5053
DOI
10.1038/nrgastro.2017.7
